Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 289-995-2 | CAS number: 90063-37-9 Extractives and their physically modified derivatives such as tinctures, concretes, absolutes, essential oils, oleoresins, terpenes, terpene-free fractions, distillates, residues, etc., obtained from Lavandula angustifolia, Labiatae.
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Skin sensitisation: skin sensitiser, in two LLNA studies (OECD 429, GLP, K1).
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 02-07 October 2002
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Remarks:
- GLP study conducted in compliance with OECD guideline 429 with a minor deviation: Relative humidity was sometimes outside of the target ranges.
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Version / remarks:
- 24th April 2002
- Deviations:
- yes
- Remarks:
- relative humidity was sometimes outside of the target ranges.
- Principles of method if other than guideline:
- Not applicable
- GLP compliance:
- yes
- Type of study:
- mouse local lymph node assay (LLNA)
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Lot/batch No.of test material: 010179
- Date of receipt: 27 September 2002
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: At room temperature and protected from light - Species:
- mouse
- Strain:
- CBA:J
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Janvier, Le Genest-Saint-Isle, France
- Females (if applicable) nulliparous and non-pregnant: Yes
- Age at study initiation: ca. 9 weeks
- Weight at study initiation: 20.5 ± 1.0 g
- Housing: Animals were housed individually in disposable crystal polystyrene cages.
- Diet: A04 C pelleted diet (UAR, Villemoisson, Epinay-sur-Orge, France), ad libitum
- Water: Tap water (filtered using a 0.22 µm filter) contained in bottles, ad libitum
- Acclimation period: At least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature: 22 ± 2°C
- Humidity: 30-70%
- Air changes: ca. 12 cycles/hour of filtered, non-recycled air
- Photoperiod: 12 hours dark / 12 hours light - Vehicle:
- acetone/olive oil (4:1 v/v)
- Concentration:
- 0, 5, 10, 25, 50 and 100% v/v
- No. of animals per dose:
- 4 females
- Details on study design:
- MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Name of test method: Local Lymph Node Assay (LLNA)
- Criteria used to consider a positive response: The test item was considered as a skin sensitizer when the SI for a dose group is ≥ 3. Other relevant criteria such as cellularity, radioactivity levels and ear thickness were also taken into account for the interpretation of results.
TREATMENT PREPARATION AND ADMINISTRATION: On Days 1, 2 and 3, a dose-volume of 25 μL of the control or dosage form preparations was applied to the dorsal surface of both ears, using an adjustable pipette fitted with a plastic tip. On Day 6, all animals of all groups received a single intravenous injection of 250 μL of 0.9% NaCl containing 20 μCi of 3H-TdR (specific activity of 25 Ci/mmol), via the tail vein. Approximately 5 hours later, the animals were killed by cervical dislocation and the auricular lymph nodes were excised. The lymph nodes were pooled for each experimental group.
For each experimental group, a single cell suspension of auricular lymph node cells (ALNC) was prepared by mechanical dissagregation in Petri dishes with the plunger of a syringe. Cell suspensions were washed with 15 mL of 0.9% NaCl and pellets obtained were re-suspended in 0.9% NaCl for numeration of lymphocytes (cellularity) and determination of their viability by exclusion of Trypan blue. Each cell suspension was then centrifuged and pellets were precipitated with 3 mL of 5% (w/v) trichloroacetic acid (TCA) in purified water at +4°C overnight. After a last centrifugation, the pellets were precipitated with 1 mL of 5% TCA. Three mL of Ultima GoldxR scintillation fluid (Packard) were added in order to measure incorporation of 3H-TdR using β-scintillation counting. The results were expressed as disintegrations/mn (dpm) per group.
Stimulation Indices (SI) were calculated according to the following formula: SI = dpm of treated group / dpm of control group
Calculation of the EC3 value (theoretical concentration of the test item resulting in a SI value of 3) was performed on the basis of a dose-effect response. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- Not applicable
- Positive control results:
- In the positive control group given HCA at the concentration of 25%, an increase in cellularity and a stimulation index exceeding the threshold value of 3 (SI = 11.05) were noted. The study was therefore considered valid.
- Key result
- Parameter:
- EC3
- Value:
- ca. 16.78
- Remarks on result:
- other: considered as a moderate skin sensitizer
- Key result
- Parameter:
- SI
- Value:
- 9.62
- Test group / Remarks:
- at the conentration group 100%
- Parameter:
- SI
- Value:
- 7.09
- Test group / Remarks:
- at the conentration group 50%
- Parameter:
- SI
- Value:
- 4.61
- Test group / Remarks:
- at the conentration group 25%
- Cellular proliferation data / Observations:
- DETAILS ON STIMULATION INDEX CALCULATION
In the proliferation assay, the observed SI values were 1.04, 1.99, 4.61, 7.09 and 9.62 at 5, 10, 25, 50 and 100%, respectively. Refer Table 7.4.1/1 for details.
CELLULAR PROLIFERATION DATA
A dose-related increase in the stimulation index was noted and the threshold positive value of 3 for the stimulation index was exceeded at the concentrations ≥ 25%, leading to a maximum SI value of 9.62 at the concentration of 100%. In the absence of local irritation, the positive lymphoproliferative responses observed at the concentrations ≥25% were attributed to delayed contact hypersensitivity.
EC3 CALCULATION
The EC3 value for the test item was equal to 16.78%.
CLINICAL OBSERVATIONS:
No clinical signs and no mortality were observed during the study.
BODY WEIGHTS
The body weight gain of the treated animals was similar to that of controls.
LOCAL IRRITATION
Dryness of the skin was noted on Day 6 in all animals given the test item undiluted. No cutaneous reactions and no noteworthy increase in ear thickness were observed in the treated groups. - Interpretation of results:
- Category 1B (indication of skin sensitising potential) based on GHS criteria
- Conclusions:
- Under the test conditions, the test item was considered as a moderate skin sensitizer (i.e. EC3 >2%) and need to be classified as "Category 1 and sub-category 1B" according to the Regulation (EC) N° 1272/2008 and according to the Globally Harmonised System of classification and labelling of chemicals (GHS). The hazard statement "H317: may cause an allergic skin reaction" with the symbol “exclamation mark” and signal word "Warning" are required.
- Executive summary:
In a Local Lymph Node Assay (LLNA) performed according to OECD Guideline 429 and in compliance with GLP, groups of CBA/J mice (4 females/dose) were topically applied with 25 µL of test item at concentrations of 5, 10, 25, 50 and 100% v/v to the dorsal surface of both ears for three consecutive days (Days 1, 2 and 3). One negative control group of four animals received the vehicle (mixture acetone/olive oil (4/1)) and one positive control group received the reference item, α-hexylcinnamaldehyde (HCA), a moderate sensitizer, at the concentration of 25%. After 2 days of resting, the proliferation of the lymph node cells in the lymph node draining the application site was measured by incorporation of tritiated methyl thymidine (Day 6). The obtained values were used to calculate stimulation indices (SI). The irritant potential of the test item was assessed in parallel by measurement of ear thickness on Days 1, 2, 3 and 6.
No mortality and no clinical signs were observed during the study. Dryness of the skin was noted on Day 6 in all animals given the test item undiluted. No cutaneous reactions and no noteworthy increase in ear thickness were observed in the treated groups. In the proliferation assay, the observed SI values were 1.04, 1.99, 4.61, 7.09 and 9.62 at 5, 10, 25, 50 and 100%, respectively. A dose-related increase in the stimulation index was noted and the threshold positive value for the SI was exceeded at the concentrations ≥ 25%. In the absence of local irritation, the positive lymphoproliferative responses observed at the concentrations ≥25% were attributed to delayed contact hypersensitivity. The EC3 value for the test item was equal to 16.78%.
The SI of the positive control was 11.05; therefore this experiment was considered valid.
Under these test conditions, the test item was considered as a moderate skin sensitizer (i.e. EC3 >2%) and need to be classified as "Category 1 and sub-category 1B" according to the Regulation (EC) N° 1272/2008 and according to the Globally Harmonised System of classification and labelling of chemicals (GHS). The hazard statement "H317: may cause an allergic skin reaction" with the symbol “exclamation mark” and signal word "Warning" are required.
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 27 November - 02 December 2002
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Remarks:
- GLP study conducted in compliance with OECD guideline 429 without any deviation
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Version / remarks:
- 24th April 2002
- Deviations:
- no
- Principles of method if other than guideline:
- Not applicable
- GLP compliance:
- yes
- Type of study:
- mouse local lymph node assay (LLNA)
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Lot/batch No.of test material: 3571-3572-3573
- Date of receipt: 18 November 2002
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: +4°C and protected from light - Species:
- mouse
- Strain:
- CBA:J
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Janvier, Le Genest-Saint-Isle, France
- Females (if applicable) nulliparous and non-pregnant: Yes
- Age at study initiation: ca. 9 weeks
- Weight at study initiation: 19.0 ± 1.3 g
- Housing: Animals were housed individually in disposable crystal polystyrene cages.
- Diet: A04 C pelleted diet (UAR, Villemoisson, Epinay-sur-Orge, France), ad libitum
- Water: Tap water (filtered using a 0.22 µm filter) contained in bottles, ad libitum
- Acclimation period: At least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature: 22 ± 2°C
- Humidity: 30-70%
- Air changes: ca. 12 cycles/hour of filtered, non-recycled air
- Photoperiod: 12 hours dark / 12 hours light - Vehicle:
- acetone/olive oil (4:1 v/v)
- Concentration:
- 0, 5, 10, 25, 50 and 100% v/v
- No. of animals per dose:
- 4 females
- Details on study design:
- MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Name of test method: Local Lymph Node Assay (LLNA)
- Criteria used to consider a positive response: The test item was considered as a skin sensitizer when the SI for a dose group is ≥ 3. Other relevant criteria such as cellularity, radioactivity levels and ear thickness were also taken into account for the interpretation of results.
TREATMENT PREPARATION AND ADMINISTRATION: On Days 1, 2 and 3, a dose-volume of 25 μL of the control or dosage form preparations was applied to the dorsal surface of both ears, using an adjustable pipette fitted with a plastic tip. On Day 6, all animals of all groups received a single intravenous injection of 250 μL of 0.9% NaCl containing 20 μCi of 3H-TdR (specific activity of 25 Ci/mmol), via the tail vein. Approximately 5 hours later, the animals were killed by cervical dislocation and the auricular lymph nodes were excised. The lymph nodes were pooled for each experimental group.
For each experimental group, a single cell suspension of auricular lymph node cells (ALNC) was prepared by mechanical dissagregation in Petri dishes with the plunger of a syringe. Cell suspensions were washed with 15 mL of 0.9% NaCl and pellets obtained were re-suspended in 0.9% NaCl for numeration of lymphocytes (cellularity) and determination of their viability by exclusion of Trypan blue. Each cell suspension was then centrifuged and pellets were precipitated with 3 mL of 5% (w/v) trichloroacetic acid (TCA) in purified water at +4°C overnight. After a last centrifugation, the pellets were precipitated with 1 mL of 5% TCA. Three mL of Ultima GoldxR scintillation fluid (Packard) were added in order to measure incorporation of 3H-TdR using β-scintillation counting. The results were expressed as disintegrations/mn (dpm) per group.
Stimulation Indices (SI) were calculated according to the following formula: SI = dpm of treated group / dpm of control group
Calculation of the EC3 value (theoretical concentration of the test item resulting in a SI value of 3) was performed on the basis of a dose-effect response. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- Not applicable
- Positive control results:
- In the positive control group given HCA at the concentration of 25%, an increase in cellularity and a stimulation index exceeding the threshold value of 3 (SI = 16.26) were noted. The study was therefore considered valid.
- Key result
- Parameter:
- EC3
- Value:
- ca. 9.6
- Remarks on result:
- other: considered as a moderate skin sensitizer
- Key result
- Parameter:
- SI
- Value:
- 15.81
- Test group / Remarks:
- at concentration of 50%
- Parameter:
- SI
- Value:
- 9.38
- Test group / Remarks:
- at the concentration group 25%
- Parameter:
- SI
- Value:
- 1.78
- Test group / Remarks:
- at the concentration group 10%
- Cellular proliferation data / Observations:
- DETAILS ON STIMULATION INDEX CALCULATION
In the proliferation assay, the observed SI values were 1.96, 1.78, 9.38, 15.81 and 13.46 at 5, 10, 25, 50 and 100%, respectively. Refer Table 7.4.1/1 for details.
CELLULAR PROLIFERATION DATA
In the treated groups, a dose-related increase in the stimulation index was noted and the threshold positive value for the SI was exceeded at the concentrations ≥ 25%, leading to a maximum SI value of 15.81 at the concentration of 50%. In the absence of local irritation, the positive lymphoproliferative responses observed at the concentrations ≥25% were attributed to delayed contact hypersensitivity.
EC3 CALCULATION
The EC3 value for the test item was equal to 9.60%.
CLINICAL OBSERVATIONS:
No clinical signs and no mortality were observed during the study.
BODY WEIGHTS
The body weight gain of the treated animals was similar to that of controls.
LOCAL IRRITATION
Except for dryness of the skin recorded on day 6 in 2/4 animals given the test item undiluted, no cutaneous reactions and no noteworthy increase in ear thickness were observed during the study. - Interpretation of results:
- Category 1B (indication of skin sensitising potential) based on GHS criteria
- Conclusions:
- Under the test conditions, the test item was considered as a moderate skin sensitizer (i.e. EC3 >2%) and need to be classified as "Category 1 and sub-category 1B" according to the Regulation (EC) N° 1272/2008 and according to the Globally Harmonised System of classification and labelling of chemicals (GHS). The hazard statement "H317: may cause an allergic skin reaction" with the symbol “exclamation mark” and signal word "Warning" are required.
- Executive summary:
In a Local Lymph Node Assay (LLNA) performed according to OECD Guideline 429 and in compliance with GLP, groups of CBA/J mice (4 females/dose) were topically applied with 25 µL of test item at concentrations of 5, 10, 25, 50 and 100% v/v to the dorsal surface of both ears for three consecutive days(Days 1, 2 and 3). One negative control group of four animals received the vehicle (mixture acetone/olive oil (4/1)) and one positive control group received the reference item, α-hexylcinnamaldehyde (HCA), a moderate sensitizer, at the concentration of 25%. After 2 days of resting, the proliferation of the lymph node cells in the lymph node draining the application site was measured by incorporation of tritiated methyl thymidine (Day 6). The obtained values were used to calculate stimulation indices (SI). The irritant potential of the test item was assessed in parallel by measurement of ear thickness on Days 1, 2, 3 and 6.
No mortality and no clinical signs were observed during the study. Except for dryness of the skin recorded on Day 6 in 2/4 animals given the test item undiluted, no cutaneous reactions and no noteworthy increase in ear thickness were observed during the study. In the proliferation assay, the observed SI values were 1.96, 1.78, 9.38, 15.81 and 13.46 at 5, 10, 25, 50 and 100%, respectively. A dose-related increase in the stimulation index was noted and the threshold positive value for the SI was exceeded at the concentrations ≥ 25%. In the absence of local irritation, the positive lymphoproliferative responses observed at the concentrations ≥25% were attributed to delayed contact hypersensitivity. The EC3 value for the test item was equal to 9.60%.
The SI of the positive control was 16.26; therefore this experiment was considered valid.
Under these test conditions, the test item was considered as a moderate skin sensitizer (i.e. EC3 >2%) and need to be classified as "Category 1 and sub-category 1B" according to the Regulation (EC) N° 1272/2008 and according to the Globally Harmonised System of classification and labelling of chemicals (GHS). The hazard statement "H317: may cause an allergic skin reaction" with the symbol “exclamation mark” and signal word "Warning" are required.
Referenceopen allclose all
Table 7.4.1/1: Skin sensitization – results
Concentrations (%) |
Vehicle control (Acetone/Olive oil) |
5 |
10 |
25 |
50 |
100 |
Positive control (HCA at 25%) |
No. of nodes per group |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
Disintegrations per minute per group (dpm) |
821.85 |
858.26 |
1635.79 |
3785.42 |
5827.33 |
7904.29 |
9084.91 |
Disintegrations per minute per node (dpm) |
102.73 |
107.28 |
204.47 |
473.18 |
728.42 |
988.04 |
1135.61 |
Stimulation Index (SI) |
- |
1.04 |
1.99 |
4.61 |
7.09 |
9.62 |
11.05 |
Increase in ear thickness (% between Day 1 and Day 6) |
2.04 |
0.00 |
-0.99 |
-4.17 |
3.13 |
5.05 |
- |
EC3 value |
- |
16.78% |
- |
Stimulation Indices, SI = dpm of treated group / dpm of control group
EC3 value = theoretical concentration resulting in a SI value of 3
Table 7.4.1/1: Skin sensitization – results
Concentrations (%) |
Vehicle control (Acetone/Olive oil) |
5 |
10 |
25 |
50 |
100 |
Positive control (HCA at 25%) |
No. of nodes per group |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
Disintegrations per minute per group (dpm) |
607.28 |
1191.41 |
1083.54 |
5698.11 |
9601.52 |
8174.35 |
9872.81 |
Disintegrations per minute per node (dpm) |
75.91 |
148.93 |
135.44 |
712.26 |
1200.19 |
1021.79 |
1234.1 |
Stimulation Index (SI) |
- |
1.96 |
1.78 |
9.38 |
15.81 |
13.46 |
16.26 |
Increase in ear thickness (% between Day 1 and Day 6) |
1.04 |
6.25 |
1.02 |
5.26 |
2.02 |
6.32 |
- |
EC3 value |
- |
9.60% |
- |
Stimulation Indices, SI = dpm of treated group / dpm of control group
EC3 value = theoretical concentration resulting in a SI value of 3
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (sensitising)
- Additional information:
In two independant studies performed according to OECD Guideline 429 and in compliance with GLP, groups of CBA/J mice (4 females/dose) were topically applied with 25 µL of test item (Huile essentielle de Lavande Etrangère mélange Bulgare/ Russe/ chinoise and Huile essentielle de lavande AOC) at concentrations of 5, 10, 25, 50 and 100% v/v to the dorsal surface of both ears for three consecutive days(Days 1, 2 and 3). One negative control group of four animals received the vehicle (mixture acetone/olive oil (4/1)) and one positive control group received the reference item, α-hexylcinnamaldehyde (HCA), a moderate sensitizer, at the concentration of 25%. After 2 days of resting, the proliferation of the lymph node cells in the lymph node draining the application site was measured by incorporation of tritiated methyl thymidine (Day 6). The obtained values were used to calculate stimulation indices (SI). The irritant potential of the test item was assessed in parallel by measurement of ear thickness on Days 1, 2, 3 and 6.
For the first test item: Huile essentielle de lavande Etrangère mélange Bulgare/ Russe/ Chinois, in the proliferation assay, the observed SI values were 1.96, 1.78, 9.38, 15.81 and 13.46 at 5, 10, 25, 50 and 100%, respectively. A dose-related increase in the stimulation index was noted and the threshold positive value for the SI was exceeded at the concentrations ≥ 25%. In the absence of local irritation, the positive lymphoproliferative responses observed at the concentrations ≥25% were attributed to delayed contact hypersensitivity. The EC3 value for the test item was equal to 9.60%.
For the second test item: Huile essentielle de lavande AOC: In the proliferation assay, the observed SI values were 1.04, 1.99, 4.61, 7.09 and 9.62 at 5, 10, 25, 50 and 100%, respectively. A dose-related increase in the stimulation index was noted and the threshold positive value for the SI was exceeded at the concentrations ≥ 25%. In the absence of local irritation, the positive lymphoproliferative responses observed at the concentrations ≥25% were attributed to delayed contact hypersensitivity. The EC3 value for the test item was equal to 16.78%.
Under these test conditions, both test items were considered as a moderate skin sensitizers (i.e. EC3 >2%) and need to be classified as "Category 1 and sub-category 1B" according to the Regulation (EC) N° 1272/2008 and according to the Globally Harmonised System of classification and labelling of chemicals (GHS). The hazard statement "H317: may cause an allergic skin reaction" with the symbol “exclamation mark” and signal word "Warning" are required.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
Harmonized classification:
The registered substance has no harmonized classification according to the Regulation (EC) No. 1272/2008.
Self-classification:
Based on the available information the substance is classified as:
- Skin Sens. 1, H317 (May cause an allergic skin reaction) according to the criteria of the Annex VI of the Regulation (EC) No. 1272/2008 (CLP).
No information was available regarding respiratory sensitisation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.